FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201996464> ?p ?o ?g. }

• W3201996464 endingPage "1026" @default.
• W3201996464 startingPage "1026" @default.
• W3201996464 abstract "Background and objectives: Hodgkin lymphoma (HL) is characterized by the presence of malignant Reed Sternberg cells. Although the current curability rate in patients with HL has increased, up to 30% of those in the advanced stages and 5% to 10% of those in limited stages of the disease, relapse. According to the studies, the relapse risk in HL decreases after 2 years. The purpose of this study is to evaluate the relapse risk and event free survival (EFS) in patients with HL treated with Doxorubicin, Bleomycin, Vinblastine and Dacarbazine (ABVD), or treated with Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone (BEACOPP) regimens. Material and methods: In an observational, consecutive-case scenario, 71 patients (median age 32 years; range 16 to 80 years) diagnosed within a 4-year timeframe were enrolled; all patients were treated according to standards of care. The average follow-up duration was 26 months. Results: The risk of relapse, in patients older than 40 years, decreased after 1 year, OR = 0.707 (95% CI 0.506 to 0.988), and 2 years, OR = 0.771 (95% CI 0.459 to 1.295), respectively. Patients in the advanced stages had a higher International Prognostic Score (IPS) (score ≥ 4). The overall survival at 2 years was 57.74% and the disease-specific survival at 2 years was 71.83%. Regardless, the chemotherapy regimen and the EFS time, advanced stage, high IPS and bulky disease were still associated with an increased relapse risk in patients with HL. Conclusions: The use of ABVD chemotherapy regimen followed by 2 years EFS was associated with a reduced relapse risk." @default.
• W3201996464 created "2021-10-11" @default.
• W3201996464 creator A5002149700 @default.
• W3201996464 creator A5009877844 @default.
• W3201996464 creator A5026764151 @default.
• W3201996464 creator A5027277727 @default.
• W3201996464 creator A5046037515 @default.
• W3201996464 creator A5049481514 @default.
• W3201996464 creator A5063573003 @default.
• W3201996464 creator A5079401394 @default.
• W3201996464 date "2021-09-27" @default.
• W3201996464 modified "2023-10-18" @default.
• W3201996464 title "Evaluation of the Relapse Risk and Survival Rate in Patients with Hodgkin Lymphoma: A Monocentric Experience" @default.
• W3201996464 cites W1920562512 @default.
• W3201996464 cites W2014698797 @default.
• W3201996464 cites W2039888190 @default.
• W3201996464 cites W2045627979 @default.
• W3201996464 cites W2065376073 @default.
• W3201996464 cites W2076334524 @default.
• W3201996464 cites W2085143233 @default.
• W3201996464 cites W2099126154 @default.
• W3201996464 cites W2103004443 @default.
• W3201996464 cites W2108597878 @default.
• W3201996464 cites W2118169390 @default.
• W3201996464 cites W2118875599 @default.
• W3201996464 cites W2119843363 @default.
• W3201996464 cites W2133260927 @default.
• W3201996464 cites W2140801657 @default.
• W3201996464 cites W2141117259 @default.
• W3201996464 cites W2211631799 @default.
• W3201996464 cites W2415747453 @default.
• W3201996464 cites W2913370447 @default.
• W3201996464 doi "https://doi.org/10.3390/medicina57101026" @default.
• W3201996464 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8540813" @default.
• W3201996464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34684063" @default.
• W3201996464 hasPublicationYear "2021" @default.
• W3201996464 type Work @default.
• W3201996464 sameAs 3201996464 @default.
• W3201996464 citedByCount "2" @default.
• W3201996464 countsByYear W32019964642023 @default.
• W3201996464 crossrefType "journal-article" @default.
• W3201996464 hasAuthorship W3201996464A5002149700 @default.
• W3201996464 hasAuthorship W3201996464A5009877844 @default.
• W3201996464 hasAuthorship W3201996464A5026764151 @default.
• W3201996464 hasAuthorship W3201996464A5027277727 @default.
• W3201996464 hasAuthorship W3201996464A5046037515 @default.
• W3201996464 hasAuthorship W3201996464A5049481514 @default.
• W3201996464 hasAuthorship W3201996464A5063573003 @default.
• W3201996464 hasAuthorship W3201996464A5079401394 @default.
• W3201996464 hasBestOaLocation W32019964641 @default.
• W3201996464 hasConcept C126322002 @default.
• W3201996464 hasConcept C141071460 @default.
• W3201996464 hasConcept C143998085 @default.
• W3201996464 hasConcept C207103383 @default.
• W3201996464 hasConcept C2776305933 @default.
• W3201996464 hasConcept C2776694085 @default.
• W3201996464 hasConcept C2776755627 @default.
• W3201996464 hasConcept C2777132456 @default.
• W3201996464 hasConcept C2778336483 @default.
• W3201996464 hasConcept C2779020855 @default.
• W3201996464 hasConcept C2779112685 @default.
• W3201996464 hasConcept C2779338263 @default.
• W3201996464 hasConcept C2779429289 @default.
• W3201996464 hasConcept C2780430958 @default.
• W3201996464 hasConcept C2780964509 @default.
• W3201996464 hasConcept C2781413609 @default.
• W3201996464 hasConcept C2992779791 @default.
• W3201996464 hasConcept C44249647 @default.
• W3201996464 hasConcept C71924100 @default.
• W3201996464 hasConceptScore W3201996464C126322002 @default.
• W3201996464 hasConceptScore W3201996464C141071460 @default.
• W3201996464 hasConceptScore W3201996464C143998085 @default.
• W3201996464 hasConceptScore W3201996464C207103383 @default.
• W3201996464 hasConceptScore W3201996464C2776305933 @default.
• W3201996464 hasConceptScore W3201996464C2776694085 @default.
• W3201996464 hasConceptScore W3201996464C2776755627 @default.
• W3201996464 hasConceptScore W3201996464C2777132456 @default.
• W3201996464 hasConceptScore W3201996464C2778336483 @default.
• W3201996464 hasConceptScore W3201996464C2779020855 @default.
• W3201996464 hasConceptScore W3201996464C2779112685 @default.
• W3201996464 hasConceptScore W3201996464C2779338263 @default.
• W3201996464 hasConceptScore W3201996464C2779429289 @default.
• W3201996464 hasConceptScore W3201996464C2780430958 @default.
• W3201996464 hasConceptScore W3201996464C2780964509 @default.
• W3201996464 hasConceptScore W3201996464C2781413609 @default.
• W3201996464 hasConceptScore W3201996464C2992779791 @default.
• W3201996464 hasConceptScore W3201996464C44249647 @default.
• W3201996464 hasConceptScore W3201996464C71924100 @default.
• W3201996464 hasIssue "10" @default.
• W3201996464 hasLocation W32019964641 @default.
• W3201996464 hasLocation W32019964642 @default.
• W3201996464 hasLocation W32019964643 @default.
• W3201996464 hasLocation W32019964644 @default.
• W3201996464 hasLocation W32019964645 @default.
• W3201996464 hasOpenAccess W3201996464 @default.
• W3201996464 hasPrimaryLocation W32019964641 @default.
• W3201996464 hasRelatedWork W1827095708 @default.
• W3201996464 hasRelatedWork W2013195780 @default.

• next